Rate My Professor Guojun Chen

Chen holds the Canada Research Chair (Tier II) in Biomaterials and Biomacromolecule Delivery. His laboratory focuses on engineering intelligent biomaterials for drug delivery toward precision medicine, with emphasis on understanding and exploiting interactions between biomaterials and biological systems. Specific research directions include cold atmospheric plasma-mediated cancer immunotherapy, biomaterials-mediated cancer immunotherapy, and non-viral genome editing. Areas of expertise encompass nanomedicine, drug and gene delivery, immunotherapeutic biomaterials, plasma therapy, and tissue engineering. Chen has secured funding including multiple CIHR Project Grants, an NSERC Discovery Grant and Launch Supplement, Canada Foundation for Innovation John R. Evans Leaders Fund support, a Canadian Cancer Society Challenge Grant, and bridge funding from the CIHR Institute of Cancer Research. His collaborative work has appeared in journals including Proceedings of the National Academy of Sciences, Science Advances, Advanced Materials, and Med. He leads projects on lung-targeted lipid nanoparticles for antiviral RNA delivery and in vivo CAR-T cell engineering platforms.